editorial
 

Targeting metabolic disorders through modulation of gut microbiota

Dr. Banshi Saboo
The last few decades have witnessed a continued surge in the prevalence of metabolic disorders, such as obesity, dyslipidemia, insulin resistance, and diabetes mellitus which poses a significant public health concern.
 

Medicolegal aspects of consent: Indian perspective

Current Issue
Volume:28
Number: 10
 

Clinical Update

Management of acute coronary syndrome with a combination of aspirin, clopidogrel and rosuvastatin
According to 2014 AHA/ACC Guidelines,1 acute coronary syndrome (ACS) refers to patients with symptoms which occur due to a partial or total blockage of a coronary artery causing myocardial ischemia (cells starving of oxygen) or infarction (cell death). ACS comprises of two clinical presentations, namely, ST elevation myocardial infarction (STEMI) and non–ST elevation acute coronary syndrome (NSTE-ACS).

Other review articles:

Tech Update

FDA clears first non-pharmacological treatment option for ADHD in children